Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

This study has been withdrawn prior to enrollment.

(Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.)

Sponsor:

Information provided by:

Millennium Pharmaceuticals, Inc.

ClinicalTrials.gov Identifier:

NCT00610792

First received: January 28, 2008

Last updated: July 13, 2009

Last verified: July 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)